Obesity in the Otsuka Long Evans Tokushima Fatty Rat: Mechanisms and Discoveries by Sheng Bi & Timothy H. Moran
July 2016 | Volume 3 | Article 211
Review
published: 27 July 2016
doi: 10.3389/fnut.2016.00021
Frontiers in Nutrition | www.frontiersin.org
Edited by: 
Patrick Christian Even, 
AgroParisTech, France
Reviewed by: 
Hervé Guillou, 
Institut National de la Recherche 
Agronomique, France  
Gary Schwartz, 
Albert Einstein College of Medicine, 
USA
*Correspondence:
Timothy H. Moran  
tmoran@jhmi.edu
Specialty section: 
This article was submitted 
to Clinical Nutrition, 
a section of the journal 
Frontiers in Nutrition
Received: 02 May 2016
Accepted: 01 July 2016
Published: 27 July 2016
Citation: 
Bi S and Moran TH (2016) Obesity in 
the Otsuka Long Evans Tokushima 
Fatty Rat: Mechanisms and 
Discoveries. 
Front. Nutr. 3:21. 
doi: 10.3389/fnut.2016.00021
Obesity in the Otsuka Long evans 
Tokushima Fatty Rat: Mechanisms 
and Discoveries
Sheng Bi1 and Timothy H. Moran1,2*
1 Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA, 
2 Global Obesity Prevention Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Understanding the neural systems underlying the controls of energy balance has been 
greatly advanced by identifying the deficits and underlying mechanisms in rodent obesity 
models. The current review focuses on the Otsuka Long Evans Tokushima Fatty (OLETF) 
rat obesity model. Since its recognition in the 1990s, significant progress has been made 
in identifying the causes and consequences of obesity in this model. Fundamental is a 
deficit in the cholecystokinin (CCK)-1 receptor gene resulting in the absence of CCK-1 
receptors in both the gastrointestinal track and the brain. OLETF rats have a deficit in 
their ability to limit the size of meals and in contrast to CCK-1 receptor knockout mice, 
do not compensate for this increase in the size of their spontaneous meals, resulting in 
hyperphagia. Prior to becoming obese and in response to pair feeding, OLETF rats have 
increased expression of neuropeptide Y (NPY) in the compact region of the dorsomedial 
hypothalamus (DMH), and this overexpression contributes to their overall hyperphagia. 
Study of the OLETF rats has revealed important differences in the organization of the 
DMH in rats and mice and elucidated previously unappreciated roles for DMH NPY in 
energy balance and glucose homeostasis.
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iNTRODUCTiON
Rodent obesity models have been critical to our understanding of the neural systems involved in 
the controls of food intake and body weight. Dissection of the genetics underlying the obesity of ob/
ob and db/db mice led not only to the discovery of leptin but also contributed greatly to the under-
standing of multiple hypothalamic peptide systems involved in energy balance. Another example 
of a genetic model that has increased our understanding of the neural systems involved in energy 
balance is the Otsuka Long Evans Tokushima Fatty (OLETF) rat. This rat obesity model was derived 
from a spontaneous obesity in an outbred colony of Long Evans rats. OLETF and a control Long 
Evans Tokushima Otsuka (LETO) lines were then developed by selective breeding. OLETF rats were 
initially studied primarily as a model of late onset type 2 diabetes, as older OLETF rats were not only 
obese but also hyperglycemic and insulin resistant (1).
Characterization of overall pancreatic function in OLETF rats demonstrated the absence of a 
pancreatic amylase response to administration of the brain gut peptide cholecystokinin (CCK) (2). 
Further studies revealed that OLETF rats had a >6 kbp deletion in the gene for the CCK-1 receptor 
that spanned the first and second exons and resulted in the absence of expression of a functional 
CCK-1 receptor (3). Thus, the OLETF rat is a CCK-1 receptor knockout model.
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CHOLeCYSTOKiNiN AND 
CHOLeCYSTOKiNiN ReCePTORS
Cholecystokinin is a gut/brain peptide that plays a variety of roles. 
Gut CCK is released from I cells in the upper intestine in response 
to the intraluminal presence of nutrients and plays a variety of 
roles in the overall digestive function. Exogenously administered 
and endogenously released CCK slow gastric emptying, modulate 
intestinal motility and stimulate gall bladder and pancreatic 
secretions. CCK also plays a role in the control of food intake 
by contributing to meal termination. Exogenously administered 
CCK reduces food intake and does so by reducing meal size (4–6). 
A role for endogenously released CCK in the controls of meal 
size is demonstrated by the ability of CCK receptor antagonists to 
increase food intake by prolonging eating – increasing meal dura-
tion and size (7, 8). The primary mechanism of action of CCK in 
the inhibition of food intake is paracrine, acting on local vagal 
afferent terminals in close apposition to the intestinal I cells (9, 
10). CCK receptors are expressed in vagal afferent cell bodies in 
the nodose ganglion and transported to abdominal vagal endings 
(11). CCK both directly activates vagal afferent fibers and also 
sensitizes vagal fibers to signals, transmitting information about 
gastric and intestinal luminal volume (12, 13).
In the brain, CCK acts as neurotransmitter/neuromodulator. 
CCK-producing neurons are widely distributed in the brain, 
and CCK neurons have been reported to be the most ubiquitous 
of all peptidergic neurons. Cell bodies are found throughout 
all layers of the cerebral cortex and are widely distributed 
throughout olfactory and limbic systems and in multiple hypo-
thalamic nuclei. In the midbrain, CCK cell bodies are found in 
the substantia nigra, the ventral tegmental area, and the raphe 
nucleus (14, 15), and CCK modulates both dopaminergic and 
serotonergic function (16).
There are two CCK receptor subtypes (17, 18). These were 
initially identified based on their relative affinity for various CCK 
fragments and analogs. CCK-1 receptors require the sulfated 
tyrosine, and these were originally characterized in rat and guinea 
pig pancreas. CCK-1 receptors exist in both low capacity, high 
affinity and high capacity, low affinity states. CCK-2 receptors 
have high affinity for unsulfated CCK and various CCK frag-
ments and were initially characterized in brain. Both receptors 
are members of the G-coupled super family of receptors. As 
well as found in pancreas and gall bladder, CCK-1 receptors 
are expressed in the nodose ganglion (and transported in vagal 
afferent fibers) and in a number of specific brain sites, including 
the dorsomedial hypothalamus (DMH) (17). There are important 
species-specific differences in the expression patterns of CCK-1 
and CCK-2 receptors, including the expression of CCK-2 and not 
CCK-1 receptors in human pancreas. However, the expression of 
CCK-1 receptors in vagal afferent neurons and in specific brain 
sites appears to be similar in rat and man (not in the mouse as 
will be discussed later).
The satiety actions of CCK depend on the interactions with 
CCK-1 receptors. Sulfated CCK-8 or sulfated longer forms (i.e., 
CCK-33, CCK-58) inhibit food intake in a dose-related fashion, 
while unsulfated CCK or shorter CCK fragments do not (4, 19). 
Furthermore, specific CCK-1 antagonist administration increases 
food intake while CCK-2 antagonists do not (7). This pharmaco-
logical specificity has been demonstrated across multiple species.
CHARACTeRiZATiON OF THe 
HYPeRPHAGiA iN OLeTF RATS
The initial discovery that OLETF rats had a deletion in the gene 
for the CCK-1 receptor led to experiments examining whether 
CCK could inhibit their food intake. OLETF rats lacking func-
tional CCK-1 receptors were shown to be insensitive to the 
feeding inhibitory actions of exogenously administered CCK. 
Characterization of their daily food intake revealed that OLETF 
rats ate meals that were about twice as large as those of LETO 
controls and, in response to this increase in the size of their meals, 
they at fewer meals. However, the decrease in meal frequency was 
not sufficient to normalize their food intake resulting in a chronic 
hyperphagia or overconsumption (Figure 1) (20). Evidence for 
the hyperphagia is evident even prior to weaning. In independ-
ent ingestion tests, in which rat pups are consuming milk off the 
floor of a test chamber, OLETF pups as young as 2 days of age 
consume significantly more sweetened milk than age-matched 
LETO controls (21). In tests assessing nursing behavior, OLETF 
pups also gain more weight during a suckling bout indicative of 
increased intake (22).
The food intake of OLETF rats is also characterized by higher 
preferences for high fat (23), sucrose and other sweet tastes (24). 
This can be demonstrated in both real feeding and sham feeding 
paradigms, implicating taste mechanisms in the preferences.
Pair feeding experiments in which the daily intake of OLETF 
rats was limited to that of paired LETO control rats revealed 
that the obesity in the OLETF rats was completely attributable 
to their hyperphagia. Pair feeding completely normalized their 
rates of body weight gain (Figure 2) as well as the size of their fat 
mass and their glucose regulation (20). Thus, the OLETF rat is an 
obesity model of disordered food intake.
CHARACTeRiZATiON OF HYPOTHALAMiC 
FUNCTiON iN OLeTF RATS
The lack of compensation for the increase in meal size in OLETF 
rats requires explanation. Chronic administration of CCK at meal 
onset results in chronic decreases in meal size but an increase in 
meal frequency such that overall food intake is not affected (5). 
These data suggest a role for CCK in meal termination, but not in 
overall food intake. Knockout of CCK-1 receptors in the mouse 
produces results that are consistent with this interpretation. 
CCK-1 knockout mice have increased meal size, but the decrease 
in meal frequency compensates for this so that CCK-1 KO mice 
have normal body weight (25, 26). Why does the absence of 
CCK-1 receptors result in obesity in the OLETF rat, but not in 
a mouse KO?
Part of the answer comes from the examination of hypo-
thalamic signaling in the OLETF rat. While mRNA expression 
for arcuate POMC and neuropeptide Y (NPY) was appropriate 
in obese or lean pair-fed OLETF rats [elevated POMC and 
reduced NPY in the obese state and normal expression in lean 
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OLETF rats pair-fed to amounts consumed by control LETO 
rats (27)], NPY expression in the compact subregion of the 
DMH was significantly elevated in pair-fed OLETF rats and 
normalized in ad lib-fed rats (27). These data suggested the 
possibility that elevations in DMH NPY might be driving the 
hyperphagia on OLETF rats. Analyses of NPY expression levels 
in juvenile OLETF rats prior to obesity were consistent with 
such an explanation. Five-week-old pre-obese OLETF rats had 
greatly elevated DMH NPY expression. Importantly, the same 
neurons expressing NPY in the DMH also expressed CCK-1 
receptors representing one of the populations of brain CCK-1 
receptors identified in the original autoradiography studies 
(27). Furthermore, direct injection of CCK into the DMH both 
reduces food intake and downregulates NPY mRNA expression 
without affecting ARC NPY expression, suggesting a role for 
CCK in modulating DMH NPY (28). In the absence of CCK-1 
receptors, DMH NPY is upregulated.
An examination of NPY expression in the mouse revealed that 
although NPY expression was evident in the ARC, its expression 
was not evident in the compact region of the DMH. NPY recep-
tors are evident in the dorsal and ventral medial subregions of 
the DMH, and NPY expression increases in response to exposure 
to a high-fat diet. A role for these in the lasting hyperphagia 
that occurs in diet-induced obesity has been suggested (29). In 
contrast to rats, mouse DMH does not contain CCK-1 receptors 
as neither binding activity nor mRNA expression, for CCK-1 
receptors are detected in the DMH (23). These data have led to 
the hypothesis that the obesity in the OLETF rats results from 
a combination of disordered satiety signaling due to the lack of 
vagal afferent CCK-1 receptors and an upregulation of DMH 
NPY that prevents complete compensation for the increased meal 
size. The CCK-1 receptor knockout mouse has similar deficits 
in the control of meal size, but in the absence of altered DMH 
signaling, appropriately compensates for chronically consuming 
larger meals.
This hypothesis was directly tested in the rat using viral-
mediated knockdown of DHM NPY in OLETF rats (30). Forty 
percent knockdown of DMH NPY mRNA expression in response 
to bilateral administration of an AAV-expressing short hairpin 
RNA (AAVshNPY) significantly reduced the food intake and 
weight gain trajectory of OLETF rats. The alteration in food 
intake was expressed as a partial reduction in the size of con-
sumed meals such that the meal size deficit in OLETF rats with 
DMH injections of AAVshNPY was similar to the meal size 
deficits in CCK-1 receptor KO mice. DMH NPY overexpression 
in control rats had the opposite effect. Overexpressing DMH NPY 
resulted in increased food intake, especially on a high-fat diet, 
and significantly elevated weight gain (30).
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FiGURe 1 | Meal patterns in LeTO and OLeTF rats (20).
0
100
200
300
400
500
5 6 7 8 9 10 11
LETO (ad lib)
OLETF (ad lib)
OLET (pair fed)
Weeks of Age
B
od
y 
W
ei
gh
t 
FiGURe 2 | Pair feeding normalized body weight in growing OLeTF 
rats (20).
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eXeRCiSe AND OLeTF OBeSiTY
The study of the OLETF rat has led to a number of important 
insights about interactions between exercise and food intake and 
the role of DMH signaling in energy balance. Providing OLETF 
rats access to a running results in a normalization of their body 
weight (31) and prevention if hyperinsulinemia (32). This is not 
simply due to the increased energy expenditure as their daily 
food intake is also greatly reduced by running wheel access, and 
their meal patterns are normalized (33). The long-term effects 
of running wheel activity depend upon the timing of access. In 
adult OLETF rats, running wheel access normalizes food intake 
and body weight, but at the cessation of access, food intake greatly 
increases, and body weight returns to levels of comparably aged 
OLETF rats that did not have access to running wheels. Thus, the 
effects of exercise are temporary and only evident during the time 
of running wheel access. In contrast, providing access to running 
wheels for a 6-week period beginning at 8 weeks of age had long-
lasting effects on both food intake and body weight in OLETF 
rats. Although food intake and body weight increased somewhat 
when access to the running wheels was stopped, OLETF rats did 
not regain weight to levels of control OLETF rats without run-
ning wheel access (33). Effects of exercise on other rodent obesity 
phenotypes have now been demonstrated as well (34–36). The 
age-dependent aspect of the effects of exercise may depend on 
epigenetic effects in pathways undergoing maturation and thus 
increasing the possibility of lasting effects when the exposure is 
at a younger age.
NOveL ACTiONS OF DMH NPY
The observation of altered DMH NPY signaling in the OLETF rat 
and how DMH knockdown rescues the obese phenotype has led 
to extensive studies of the roles of DMH NPY in various aspects 
of energy balance. As mentioned above, overexpression of DMH 
NPY leads to increased food intake and body weight, especially 
when rats are presented with a high-fat diet (30).
These data led to a more careful examination of the conse-
quences of altered DMH NPY signaling. Knockdown of NPY in 
the DMH in normal weight Sprague-Dawley rats has been dem-
onstrated to reduce the size of fat depots and ameliorate high-fat 
diet-induced hyperphagia and obesity. Furthermore, DMH NPY 
knockdown resulted in the development of brown adipocytes in 
inguinal white adipose tissue that was characterized by increased 
uncoupling protein 1 expression. DMH NPY knockdown also 
increased energy expenditure and enhanced the thermogenic 
response to a cold environment. This knockdown also enhanced 
insulin sensitivity. These data identified novel roles for DMH NPY 
in modulating adipose tissue, thermogenesis, insulin sensitivity, 
and energy expenditure (37).
Further work has revealed a novel modulator of DMH NPY 
signaling. Gene expression profiling of the DMH in response to 
exercise revealed an elevation of the expression of transthyretin 
(TTR), best known as a blood and cerebrospinal fluid transporter 
of thyroxine and retinol. To test the hypothesis that TTR may 
play a role in modulating signaling-related energy balance in 
the DMH, we examined the effects of brain TTR on food intake 
and body weight and have further determined hypothalamic 
signaling that may underlie its feeding effect in rats. We found 
that icv administration of TTR in normal growing rats decreased 
food intake and body weight. Furthermore, TTR administration 
decreased NPY levels in the DMH. Chronic icv infusion of TTR 
in OLETF rats reversed their hyperphagia and obesity. Overall, 
these studies examining factors that might modulate DMH NPY 
demonstrated a novel anorectic action of central TTR in the 
control of energy balance (38), providing a potential novel target 
for obesity treatment.
SUMMARY
Work with the OLETF rat has not only been focused on identify-
ing the mechanisms underlying its obesity but also served as a 
vehicle for uncovering multiple novel mechanisms involved in 
the overall controls of energy balance.
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